Shai Novik
Patrimonio netto: 6 M $ in data 31/05/2026
Patrimonio netto: 6 M $ in data 31/05/2026
Shai A. Novik was the founder of OPKO Biologics Ltd., serving as President from 2001 to 2014.
Mr. Novik is the founder of InnoVision Labs, Inc., serving as Chairman.
Mr. Novik is also the founder of Stentomics, Inc. Mr. Novik is previously the Executive Chairman of Enlivex Therapeutics Ltd. since 2014, Director of Odysseus Ventures Ltd., and Director of InnoVision Labs, Inc. since 2013.
Former positions include Chairman of Autovative Products, Inc. in 2013, Chairman of Enlivex Therapeutics Ltd., Managing Director of A-Online Capital (A.O.C.) Ltd. in 2002, Director of Cazador Acquisition Corp.
Ltd. from 2010 to 2012, Director of Ucansi, Inc., Chief Operating Officer & Head-Strategic Planning of THCG, Inc. from 1998 to 2000, and Chief Operating Officer of Rogerscasey, Inc. Education includes an MBA from Cornell University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ENLIVEX LTD. 2,89% | 18/03/2026 | 6.974.017 ( 2,89% ) | 6 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENLIVEX LTD. | Presidente | 01/01/2014 |
| INNOVISION LABS, INC. | Direttore/Membro del Consiglio | 01/01/2013 |
Stentomics, Inc. | Fondatore | 06/09/2010 |
Odysseus Ventures Ltd. | Direttore/Membro del Consiglio | 06/09/2010 |
| Società | Posizione | Fine |
|---|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Fondatore | 01/01/2014 |
Ucansi, Inc.
Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Direttore/Membro del Consiglio | 12/08/2013 |
Autovative Products, Inc.
Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Presidente | 12/08/2013 |
Cazador Acquisition Corp. Ltd.
Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Direttore/Membro del Consiglio | 04/10/2012 |
| A-ONLINE CAPITAL (A.O.C) LTD. | Presidente | 01/01/2002 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
THCG, Inc.
THCG, Inc. Finance/Rental/LeasingFinance Provides venture funding, venture development, and venture banking services | Finance |
A-Online Capital (A.O.C.) Ltd.
A-Online Capital (A.O.C.) Ltd. Packaged SoftwareTechnology Services Develops trading and investment portfolio analysis software solutions | Technology Services |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
Autovative Products, Inc.
Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Distribution Services |
Cazador Acquisition Corp. Ltd.
Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rogerscasey, Inc.
Rogerscasey, Inc. Investment ManagersFinance Provides investment consulting services | Finance |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Stentomics, Inc. | |
Ucansi, Inc.
Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Technology Services |
Odysseus Ventures Ltd. | |
InnoVision Labs, Inc.
InnoVision Labs, Inc. Packaged SoftwareTechnology Services Operates as visual neuroscience software technology company | Technology Services |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale